BPC 157 supports the formation and maintenance of blood vessels through its interaction with the nitric oxide system, aiding tissue repair and healing
Most pharmacies will still wait for the PCAC vote before actually compounding, but the legal scaffolding for blanket refusal has been removed
Emerging investigations indicate that BPC-157 may also aid in collagen synthesis and pain relief [26, 27]
Its ~5day halflife allows convenient onceweekly subcutaneous dosing [1]
It is theorized that this process could involve the activation of the PI3K-Akt and JAK2-STAT5 pathways (pathways with essential roles in cell growth, survival, and metabolism), along with a reduction in NF-B-mediated gene transcription (proinflammatory pathways that can lead to cell damage and death)
The physician says, okay, you want to make sure that it's real and you want to make sure that it's clean, no contaminants